EMEA-000527-PIP03-13
Key facts
Invented name |
Lucentis
|
Active substance |
ranibizumab
|
Therapeutic area |
Ophthalmology
|
Decision number |
P/0185/2014
|
PIP number |
EMEA-000527-PIP03-13
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravitreal use
|
Contact for public enquiries |
Novartis Europharm Limited
|
Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|